Despite the recent controversy as to the specificity of the Kveim test in sarcoidosis (Lancet, 1971; British Medical Journal, 1971; Scadding, 1971 Scadding, , 1972 , that test remains of considerable value as a diagnostic tool. In consequence, various attempts are being made to develop in-vitro Kveim tests (Bendixen and S0borg, 1969; Hardt and Wanstrup, 1969; Becker, Krull, Deicher, and Kalden, 1972; Topilsky, Siltzbach, Williams, and Glade, 1972) . They are based on the work of S0borg and Bendixen (1967) , who showed that sensitized lymphocytes, as a result of tuberculin and brucella antigen stimulation, produce a soluble leucocyte/macrophage migration inhibition factor (MIF) which correlates with the results of delayed hypersensitivity skin testing.
We have investigated the in-vitro response of peripheral lymphocytes from patients with sarcoidosis and controls to stimulation by sarcoid (Kveim material) and normal splenic homogenates using guinea-pig macrophages as the indicator cells and refer to this procedure as the Kmif test (Kveiminduced macrophage inhibition factor) (Jones Williams, 1971 (Dolby, 1969) . The lymphocyterich supernatant was washed several times using Eagle's minimal essential medium containing 20,' foetal calf serum and the cells were counted and finally resuspended in the above medium at a concentration of approximately I x 106 cells/ml. The cells were then cultured for 72 hours in 1 ml aliquots containing either 0-2 ml Kveim material (250 ,ug/ml as measured by protein content) or 0-2 ml of the normal spleen suspensions. After 72 hours the supernatants were removed and duplicates pooled. The supernatants were equilibrated by the addition of 0-2 ml Kveim material to the control tubes and 0-2 ml normal spleen to the experimental tubes. All tests were performed in duplicate and some in triplicate, depending on the number of lymphocytes available after cell separation.
ASSAY FOR MIGRATION INHIBITION FACTOR
Macrophages were obtained from unsensitized guinea-pigs by inoculating 20 ml of Eagle's medium (containing 5iu/ml heparin) intraperitoneally and withdrawing the fluid after 10 minutes. 
Results
In the 30 sarcoid patients tested with Kveim material (Fig. 1) Our results confirm the findings of Becker et al (1972) and of Goldstein, Janick, and Schultz (1972) who showed that the leucocyte migration test is more often positive in patients with hilar lymphadenopathy than in those with more extensive disease and is thus similar to the results of Kveim testing. We also confirm the somewhat surprising finding of Becker et al that the test is more often positive in patients with a longer rather than a shorter history, which is at variance with the results of Kveim testing.
As in the Kveim test (Siltzbach and Waraich, 1969) , steroid treatment considerably influenced our results. Three of the five Kmif-negative subjects were on steroids and in one case retesting while on steroid treatment showed a reversal of the test from positive to negative. This is in agreement with the findings of Willoughby and Mitchell (1971) who used Kveim antigen in the leucocyte migration test in a series of patients with Crohn's disease.
We have found a good correlation in subjects not on steroids between the Kmif and Kveim test (80% concordance) which agrees with earlier reports seven out of seven (Hardt and Wanstrup, 1969) and 12 out of 13 (Becker et al, 1972) . Despite a careful search we have no technical or clinical explanation for our five discordant results which were evenly distributed between the two tests and this must await testing of larger numbers. Excluding steroid therapy, the overall percentages of positive patients were similar with both tests, namely, Kmif 77 % and Kveim 80%, and using both tests 90%.
The Kmif test, like the Kveim test, is unfortunately not specific for patients with sarcoidosis. We have found (unpublished) positive tests in two of seven cases with parenchymal pulmonary tuberculosis and five of 30 cases with Crohn's disease. Brostoff and Walker (1971) , using the same unphenolized Kveim material as ourselves, found that 47% of patients with Crohn's disease showed leucocyte migration inhibition, and they obtained consistently negative results in 24 patients with idiopathic proctocolitis. Further, Brostoff and Walker, in contrast to our findings, found that positive tests were unrelated to the severity of the disease and to corticosteroid therapy. Caspary and Field (1971) have shown macrophage mobility inhibited in two patients with Crohn's disease, using sarcoid spleen suspensions from an unstated source. Willoughby and Mitchell (1971) and Pagaltsos, Kumar, Parneen, Willoughby, and Dawson (1971) (1972) are due to their use of small concentrations, 8 ,ug per ml as compared to our 250 ,ug per ml, and that of Becker et al (1972) who used 70 ,ug per ml.
Positive in-vitro Kveim tests have also been previously reported in normal subjects. Becker et al (1972) found two positive tests in 10 subjects. Our one positive case, a man aged 24, was Mantoux negative (10 TU), Kveim negative, and showed no clinical or radiological evidence of sarcoidosis or other disease and no relevant past history. The test will be repeated on this subject to exclude the interesting possibility of future development of sarcoidosis.
Despite these shortcomings, the Kmif test constitutes a rapid method of Kveim testing, obviates the necessity for biopsies, and avoids dispute in histological interpretation, in particular the danger occasioned by the presence of foreign bodies when sections are read by inexperienced observers.
The development of in-vitro tests of cellular immunity (Glade, Broder, Grotsky, and Hirschhorn, 1971) provides exciting possibilities for the future investigation of potential antigens, sensitivity states, and diagnosis of disease.
